Gut Microbiota Predicts Body Fat Change Following a Low-energy Diet: a PREVIEW Intervention Study

Overview

Journal Genome Med

Publisher Biomed Central

Specialty Genetics

Date 2022 May 22

PMID 35599315

Authors

Ching Jian

Marta Paulino Silvestre

Danielle Middleton

Katri Korpela

Elli Jalo

David Broderick

Willem Meindert de Vos

Mikael Fogelholm

Mike William Taylor

Anne Raben

Sally Poppitt

Anne Salonen

Affiliations

Soon will be listed here.

Abstract

Background: Low-energy diets (LEDs) comprise commercially formulated food products that provide between 800 and 1200 kcal/day (3.3-5 MJ/day) to aid body weight loss. Recent small-scale studies suggest that LEDs are associated with marked changes in the gut microbiota that may modify the effect of the LED on host metabolism and weight loss. We investigated how the gut microbiota changed during 8 weeks of total meal replacement LED and determined their associations with host response in a sub-analysis of 211 overweight adults with pre-diabetes participating in the large multicentre PREVIEW (PREVention of diabetes through lifestyle intervention and population studies In Europe and around the World) clinical trial.

Methods: Microbial community composition was analysed by Illumina sequencing of the hypervariable V3-V4 regions of the 16S ribosomal RNA (rRNA) gene. Butyrate production capacity was estimated by qPCR targeting the butyryl-CoA:acetate CoA-transferase gene. Bioinformatics and statistical analyses, such as comparison of alpha and beta diversity measures, correlative and differential abundances analysis, were undertaken on the 16S rRNA gene sequences of 211 paired (pre- and post-LED) samples as well as their integration with the clinical, biomedical and dietary datasets for predictive modelling.

Results: The overall composition of the gut microbiota changed markedly and consistently from pre- to post-LED (P = 0.001), along with increased richness and diversity (both P < 0.001). Following the intervention, the relative abundance of several genera previously associated with metabolic improvements (e.g., Akkermansia and Christensenellaceae R-7 group) was significantly increased (P < 0.001), while flagellated Pseudobutyrivibrio, acetogenic Blautia and Bifidobacterium spp. were decreased (all P < 0.001). Butyrate production capacity was reduced (P < 0.001). The changes in microbiota composition and predicted functions were significantly associated with body weight loss (P < 0.05). Baseline gut microbiota features were able to explain ~25% of variation in total body fat change (post-pre-LED).

Conclusions: The gut microbiota and individual taxa were significantly influenced by the LED intervention and correlated with changes in total body fat and body weight in individuals with overweight and pre-diabetes. Despite inter-individual variation, the baseline gut microbiota was a strong predictor of total body fat change during the energy restriction period.

Trial Registration: The PREVIEW trial was prospectively registered at ClinicalTrials.gov ( NCT01777893 ) on January 29, 2013.

Citing Articles

Dietary Restrictions and Cancer Prevention: State of the Art.

Caprara G, Pallavi R, Sanyal S, Pelicci P Nutrients. 2025; 17(3).

PMID: 39940361 PMC: 11820753. DOI: 10.3390/nu17030503.

Synergistic impact of Salmonella typhimurium and Eimeria spp. coinfection on turkey poults: Growth performance, salmonella colonization, and ceca microbiota insights.

Rafieian-Naeini H, Ko H, Goo D, Choppa V, Gudidoddi S, Katha H Poult Sci. 2024; 104(1):104568.

PMID: 39647353 PMC: 11667029. DOI: 10.1016/j.psj.2024.104568.

Gut microbiota and metabolic responses to a 12-week caloric restriction combined with strength and HIIT training in patients with obesity: a randomized trial.

Nechalova L, Bielik V, Hric I, Babicova M, Baranovicova E, Grendar M BMC Sports Sci Med Rehabil. 2024; 16(1):239.

PMID: 39639405 PMC: 11619444. DOI: 10.1186/s13102-024-01029-7.

Shen-Bai-Jie-Du decoction suppresses the progression of colorectal adenoma to carcinoma through regulating gut microbiota and short-chain fatty acids.

Huang M, Zhang Y, Ni M, Shen M, Tao Y, Shen W Chin Med. 2024; 19(1):149.

PMID: 39465423 PMC: 11514841. DOI: 10.1186/s13020-024-01019-4.

Gut Microbiota and Oral Contraceptive Use in Women with Polycystic Ovary Syndrome: A Systematic Review.

Wydra J, Szlendak-Sauer K, Zgliczynska M, Zeber-Lubecka N, Ciebiera M Nutrients. 2024; 16(19).

PMID: 39408349 PMC: 11478613. DOI: 10.3390/nu16193382.

References

Chong C, Orr D, Plank L, Vatanen T, OSullivan J, Murphy R . Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients. 2020; 12(4). PMC: 7230525. DOI: 10.3390/nu12040937. View

Fu B, Randolph T, Lim U, Monroe K, Cheng I, Wilkens L . Temporal Variability and Stability of the Fecal Microbiome: The Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev. 2018; 28(1):154-162. PMC: 6625800. DOI: 10.1158/1055-9965.EPI-18-0348. View

Korpela K, Flint H, Johnstone A, Lappi J, Poutanen K, Dewulf E . Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One. 2014; 9(6):e90702. PMC: 3946202. DOI: 10.1371/journal.pone.0090702. View

Di Lorenzo F, De Castro C, Silipo A, Molinaro A . Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions. FEMS Microbiol Rev. 2019; 43(3):257-272. DOI: 10.1093/femsre/fuz002. View

Heianza Y, Qi L . Gene-Diet Interaction and Precision Nutrition in Obesity. Int J Mol Sci. 2017; 18(4). PMC: 5412371. DOI: 10.3390/ijms18040787. View

Christensen P, Larsen T, Westerterp-Plantenga M, Macdonald I, Martinez J, Handjiev S . Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW). Diabetes Obes Metab. 2018; 20(12):2840-2851. PMC: 6282840. DOI: 10.1111/dom.13466. View

Gurung M, Li Z, You H, Rodrigues R, Jump D, Morgun A . Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020; 51:102590. PMC: 6948163. DOI: 10.1016/j.ebiom.2019.11.051. View

Jian C, Luukkonen P, Sadevirta S, Yki-Jarvinen H, Salonen A . Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults. Clin Nutr. 2020; 40(1):207-216. DOI: 10.1016/j.clnu.2020.05.008. View

Dao M, Sokolovska N, Brazeilles R, Affeldt S, Pelloux V, Prifti E . A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity. Front Physiol. 2019; 9:1958. PMC: 6371001. DOI: 10.3389/fphys.2018.01958. View

10.

Hjorth M, Roager H, Larsen T, Poulsen S, Licht T, Bahl M . Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention. Int J Obes (Lond). 2017; 42(3):580-583. PMC: 5880576. DOI: 10.1038/ijo.2017.220. View

11.

Henning S, Yang J, Hsu M, Lee R, Grojean E, Ly A . Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice. Eur J Nutr. 2017; 57(8):2759-2769. PMC: 7367598. DOI: 10.1007/s00394-017-1542-8. View

12.

Damms-Machado A, Mitra S, Schollenberger A, Kramer K, Meile T, Konigsrainer A . Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015; 2015:806248. PMC: 4330959. DOI: 10.1155/2015/806248. View

13.

Johnson A, Vangay P, Al-Ghalith G, Hillmann B, Ward T, Shields-Cutler R . Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans. Cell Host Microbe. 2019; 25(6):789-802.e5. DOI: 10.1016/j.chom.2019.05.005. View

14.

Louis P, Flint H . Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol. 2007; 73(6):2009-12. PMC: 1828812. DOI: 10.1128/AEM.02561-06. View

15.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

16.

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S . Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019; 25(7):1096-1103. PMC: 6699990. DOI: 10.1038/s41591-019-0495-2. View

17.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

18.

Liu H, Wang J, He T, Becker S, Zhang G, Li D . Butyrate: A Double-Edged Sword for Health?. Adv Nutr. 2018; 9(1):21-29. PMC: 6333934. DOI: 10.1093/advances/nmx009. View

19.

Hughes R, Marco M, Hughes J, Keim N, Kable M . The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models-Part I: Overview of Current Methods. Adv Nutr. 2019; 10(6):953-978. PMC: 6855943. DOI: 10.1093/advances/nmz022. View

20.

Maruvada P, Leone V, Kaplan L, Chang E . The Human Microbiome and Obesity: Moving beyond Associations. Cell Host Microbe. 2017; 22(5):589-599. DOI: 10.1016/j.chom.2017.10.005. View